- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT06144593
Den metabolske virkningen av intermitterende karbohydratrestriksjoner hos personer med type 2-diabetes (INTERCARB)
The primary aim of this randomized cross-over intervention study is to investigate the effect of 16 days of intermittent carbohydrate restriction (alternating between two days of a conventional control diet and, two days of carbohydrate restriction to 10E% (~70-90 grams)) on 24-hour average sensor glucose (primary outcome) in individuals with type 2 diabetes compared with a 16 day control period with a conventional diet. 24-hour average sensor glucose is measured by patient-blinded continuous glucose monitoring (CGM) during the intervention and control period.
Studieoversikt
Status
Intervensjon / Behandling
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: Amanda Schaufuss, MSc
- Telefonnummer: +4530270261
- E-post: amanda.schaufuss@sund.ku.dk
Studiesteder
-
-
-
Hvidovre, Danmark, 2650
- Rekruttering
- Department of Endocrinology, Hvidovre Hospital
-
Ta kontakt med:
- Kirstine Nyvold Bojsen-Møller, MD, PhD
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion criteria:
- Men or women
- 35-75 years old
- BMI >27 kg/m2
- Known type 2 diabetes in stable glucose lowering therapy (for three months) or with HbA1c >48 mmol/mol if no glucose lowering therapy
Exclusion criteria:
- Anemia (hemoglobin <8 mmol/L for men and <7 mmol/L for women)
- Thyroid disease if not well controlled based on patient reporting and/or the most recent measurement of TSH.
- Treatment with insulin or sulfonylurea
- Treatment with systemic corticosteroids
- Severely dysregulated diabetes defined by HbA1c >70 mmol/mol
- Kidney failure (eGFR <30 ml/min/1.73 m²) based on patient reporting and/or the most recent control measurement.
- History of advanced liver fibrosis or cirrhosis
- Food allergies (including lactose and gluten intolerance)
- Vegetarian/vegan diet or following of specific dietary plans
- Alcohol consumptions >84/168 g/week (women/men)
- Strenuous activity level > 120 minutes per week
- Weight loss (>5 kg) within the last three months or previous bariatric surgery
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Annen
- Tildeling: Randomisert
- Intervensjonsmodell: Crossover-oppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Intermittent carbohydrate restriction
16 days of intermittent carbohydrate restriction: a controlled dietary regime alternating between two days of restricting carbohydrate intake to 70-90 grams, and two days of a conventional control diet. Protein content is matched between diets. All food is provided. |
Intermittent carbohydrate restriction |
|
Ingen inngripen: Control arm
During the control period (16 days) the macronutrient composition matches that of the non-carbohydrate-restricted days of the intermittent carbohydrate intervention. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
24-hour average sensor glucose
Tidsramme: 24-hour average sensor glucose is measured as the average of eight consecutive days (starting from two days post sensor mounting).
|
A patient-blinded continuous glucose monitoring (CGM) is worn during the 16 day intervention and control period. |
24-hour average sensor glucose is measured as the average of eight consecutive days (starting from two days post sensor mounting).
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Fasting plasma concentrations of triacylglycerols
Tidsramme: day 18 adjusted for baseline
|
Fasting plasma concentrations of triacylglycerols measured on the day before and the day after the dietary intervention (i.e. day 0 and day 18) and on the day before and the day after the control period (i.e. day 0 and day 18). |
day 18 adjusted for baseline
|
Andre resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Explorative outcomes - Questionnaires on quality of life
Tidsramme: day 18
|
Participants will complete the questionnaires 'Problem Areas In Diabetes' & 'World Health Organisation-Five Well-Being Index'. |
day 18
|
|
Explorative outcomes - Qualitative evaluation to assess feasibility of the dietary strategy
Tidsramme: day 18
|
A semi-structured evaluation interview to assess social context, eating practices, compliance to, and feasibility and acceptability of the intermittent carbohydrate restriction regime will be carried out. |
day 18
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
- Sykdommer i det endokrine systemet
- Ernæringsforstyrrelser
- Metabolske sykdommer
- Overernæring
- Kroppsvekt
- Glukosemetabolismeforstyrrelser
- Sukkersyke
- Insulinresistens
- Hyperinsulinisme
- Patologiske tilstander, tegn og symptomer
- Ernæringsmessige og metabolske sykdommer
- Tegn og symptomer
- Overvektig
- Overvekt
- Diabetes mellitus, type 2
- Metabolsk syndrom
Andre studie-ID-numre
- INTERCARB - H-23043085
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .